日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Selective anti-CXCR2 receptor blockade by AZD5069 inhibits CXCL8-mediated pro-tumorigenic activity in human thyroid cancer cells in vitro.

AZD5069 选择性阻断 CXCR2 受体,可抑制体外人甲状腺癌细胞中 CXCL8 介导的促肿瘤活性

Coperchini F, Greco A, Petrosino E, Croce L, Teliti M, Marchesi N, Pascale A, Calì B, Pignatti P, Magri F, Uddin M, Rotondi M